Oncolytic viruses in radiation oncology

Radiotherapy and Oncology

Volumn 99, Issue 3, 2011, Pages 262-270

  Touchefeu, Yann ^a,b   Vassaux, Georges ^b   Harrington, Kevin J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSERM   (France)

Author keywords

DNA damage; Oncolytic viruses; Radiotherapy

Indexed keywords

ADENOVIRUS DELTA 24 ARGINYLGLYCYLASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID; ATM PROTEIN; BETA GALACTOSIDASE; BETA GALACTOSIDE; BRCA1 PROTEIN; CARCINOEMBRYONIC ANTIGEN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; CV 706; DNA DEPENDENT PROTEIN KINASE; EARLY GROWTH RESPONSE FACTOR 1; G 207; GREEN FLUORESCENT PROTEIN; GROWTH ARREST AND DNA DAMAGE REPAIR 34; HISTONE H2AX; IODIDE; MEMBRANE COFACTOR PROTEIN; ONCOLYTIC ADENOVIRUS; ONCOLYTIC VIRUS; ONYX 015; PROTEIN P21; PROTEIN P53; REOVIRUS VECTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS VECTOR;

ADENOVIRUS 5; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CATALYSIS; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DEATH; COLORECTAL CANCER; CYTOTOXICITY; DNA CROSS LINKING; DNA DAMAGE; DNA MICROARRAY; DNA REPAIR; DNA STRAND BREAKAGE; DOWN REGULATION; EXTERNAL BEAM RADIOTHERAPY; GENE DELETION; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HEAD AND NECK TUMOR; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HISTOLOGY; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; MEASLES VIRUS; MELANOMA; MICROARRAY ANALYSIS; MITOSIS; NONHUMAN; ONCOLYTIC VIROTHERAPY; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN CROSS LINKING; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; REOVIRUS; REVIEW; SINGLE DRUG DOSE; THYROID FOLLICLE CELL; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR REGRESSION; TUMOR VOLUME; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION;

COMBINED MODALITY THERAPY; DNA DAMAGE; HUMANS; NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; RADIATION ONCOLOGY; SIGNAL TRANSDUCTION;

EID: 79960365660     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.05.078     Document Type: Review

References (105)

1. Y. Touchefeu, K.J. Harrington, J.P. Galmiche, and G. Vassaux Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology Aliment Pharmacol Ther 32 2010 953 968
2. T.C. Liu, and D. Kirn Gene therapy progress and prospects cancer: oncolytic viruses Gene Ther 15 2008 877 884 (Pubitemid 351791475)
3. D.H. Kirn, and S.H. Thorne Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer Nat Rev Cancer 9 2009 64 71
4. K. Ottolino-Perry, J.S. Diallo, B.D. Lichty, J.C. Bell, and J.A. McCart Intelligent design: combination therapy with oncolytic viruses Mol Ther 18 2010 251 263
5. P.S. Adusumilli, B.M. Stiles, and M.K. Chan Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer Ann Thorac Surg 80 2005 409 416 [discussion 416-407]
6. S.J. Advani, G.S. Sibley, and P.Y. Song Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors Gene Ther 5 1998 160 165 (Pubitemid 28077742)
7. A. Bieler, K. Mantwill, and R. Holzmuller Impact of radiation therapy on the oncolytic adenovirus dl520: implications on the treatment of glioblastoma Radiother Oncol 86 2008 419 427 (Pubitemid 351343876)
8. Y. Chen, T. DeWeese, and J. Dilley CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity Cancer Res 61 2001 5453 5460 (Pubitemid 32694926)
9. J. Dilley, S. Reddy, and D. Ko Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity Cancer Gene Ther 12 2005 715 722 (Pubitemid 41045570)
10. S.O. Freytag, D. Paielli, and M. Wing Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model Int J Radiat Oncol Biol Phys 54 2002 873 885
11. S. Ganesh, M. Gonzalez-Edick, and D. Gibbons Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer Cancer Gene Ther 16 2009 383 392
12. B. Geoerger, J. Grill, and P. Opolon Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts Br J Cancer 89 2003 577 584 (Pubitemid 37026446)
13. M. Hingorani, C.L. White, and S. Zaidi Therapeutic effect of sodium iodide symporter gene therapy combined with external beam radiotherapy and targeted drugs that inhibit DNA repair Mol Ther 18 2010 1599 1605
14. W.R. Jarnagin, J.S. Zager, and M. Hezel Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy Cancer Gene Ther 13 2006 326 334 (Pubitemid 43255770)
15. T.J. Jorgensen, S. Katz, and E.K. Wittmack Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer Neoplasia 3 2001 451 456 (Pubitemid 32988816)
16. S.H. Kim, R.J. Wong, and D.A. Kooby Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck Eur J Cancer 41 2005 313 322 (Pubitemid 40126965)
17. M.L. Lamfers, J. Grill, and C.M. Dirven Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy Cancer Res 62 2002 5736 5742 (Pubitemid 35204729)
18. C. Liu, J.N. Sarkaria, and C.A. Petell Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme Clin Cancer Res 13 2007 7155 7165 (Pubitemid 350276902)
19. C. Liu, Y. Zhang, and M.M. Liu Evaluation of continuous low dose rate versus acute single high dose rate radiation combined with oncolytic viral therapy for prostate cancer Int J Radiat Biol 86 2010 220 229
20. S. Nandi, I.V. Ulasov, and M.A. Tyler Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells Cancer Res 68 2008 5778 5784
21. G. Portella, R. Pacelli, and S. Libertini ONYX-015 enhances radiation-induced death of human anaplastic thyroid carcinoma cells J Clin Endocrinol Metab 88 2003 5027 5032 (Pubitemid 37357559)
22. K.R. Rogulski, S.O. Freytag, and K. Zhang In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy Cancer Res 60 2000 1193 1196 (Pubitemid 30151981)
23. K. Twigger, L. Vidal, and C.L. White Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy Clin Cancer Res 14 2008 912 923 (Pubitemid 351231176)
24. M. Urano, F. He, A. Minami, C.C. Ling, and G.C. Li Response to multiple radiation doses of human colorectal carcinoma cells infected with recombinant adenovirus containing dominant-negative Ku70 fragment Int J Radiat Oncol Biol Phys 77 2010 877 885
25. M. Zhang, S. Li, J. Li, W.D. Ensminger, and T.S. Lawrence Ionizing radiation increases adenovirus uptake and improves transgene expression in intrahepatic colon cancer xenografts Mol Ther 8 2003 21 28 (Pubitemid 36939293)
26. S.O. Freytag, B. Movsas, and I. Aref Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer Mol Ther 15 2007 1016 1023 (Pubitemid 46621661)
27. S.O. Freytag, H. Stricker, and J. Pegg Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer Cancer Res 63 2003 7497 7506 (Pubitemid 37413494)
28. K.J. Harrington, M. Hingorani, and M.A. Tanay Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck Clin Cancer Res 16 2010 4005 4015
29. K.J. Harrington, E.M. Karapanagiotou, and V. Roulstone Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers Clin Cancer Res 16 2010 3067 3077
30. A. Immonen, M. Vapalahti, and K. Tyynela AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study Mol Ther 10 2004 967 972 (Pubitemid 39419922)
31. A.J. Mundt, S. Vijayakumar, and J. Nemunaitis A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities Clin Cancer Res 10 2004 5747 5753 (Pubitemid 39180951)
32. N. Senzer, S. Mani, and A. Rosemurgy TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors J Clin Oncol 22 2004 592 601 (Pubitemid 41095061)
33. S.G. Swisher, J.A. Roth, and R. Komaki Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy Clin Cancer Res 9 2003 93 101 (Pubitemid 36109720)
34. B.S. Teh, G. Ayala, and L. Aguilar Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data Int J Radiat Oncol Biol Phys 58 2004 1520 1529 (Pubitemid 38438316)
35. M.L. Lamfers, S. Idema, and L. Bosscher Differential effects of combined Ad5-delta 24RGD and radiation therapy in in vitro versus in vivo models of malignant glioma Clin Cancer Res 13 2007 7451 7458
36. B.H. Park, T. Hwang, and T.C. Liu Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial Lancet Oncol 9 2008 533 542
37. T. Egami, K. Ohuchida, and K. Mizumoto Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake Clin Cancer Res 14 2008 1859 1867 (Pubitemid 351469473)
38. J. Qian, J. Yang, A.F. Dragovic, E. Abu-Isa, T.S. Lawrence, and M. Zhang Ionizing radiation-induced adenovirus infection is mediated by Dynamin 2 Cancer Res 65 2005 5493 5497 (Pubitemid 40911146)
39. M. Hingorani, C.L. White, and S. Zaidi Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: implications for sodium iodide symporter gene therapy Clin Cancer Res 14 2008 4915 4924
40. J. Chou, and B. Roizman Herpes simplex virus 1 gamma(1)34.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage Proc Natl Acad Sci USA 91 1994 5247 5251 (Pubitemid 24174303)
41. J. Chou, E.R. Kern, R.J. Whitley, and B. Roizman Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture Science 250 1990 1262 1266 (Pubitemid 120031840)
42. C.M. Kramm, M. Chase, and U. Herrlinger Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy Hum Gene Ther 8 1997 2057 2068 (Pubitemid 28072576)
43. P.S. Adusumilli, M.K. Chan, and M. Hezel Radiation-induced cellular DNA damage repair response enhances viral gene therapy efficacy in the treatment of malignant pleural mesothelioma Ann Surg Oncol 14 2007 258 269 (Pubitemid 44954297)
44. P. Baril, P. Martin-Duque, and G. Vassaux Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapy Br J Pharmacol 159 2010 761 771
45. A. Boland, M. Ricard, and P. Opolon Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy Cancer Res 60 2000 3484 3492 (Pubitemid 30482168)
46. J. Faivre, J. Clerc, and R. Gerolami Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in wistar rats Cancer Res 64 2004 8045 8051 (Pubitemid 39446941)
47. A.W. Gaut, G. Niu, K.J. Krager, M.M. Graham, D.K. Trask, and F.E. Domann Genetically targeted radiotherapy of head and neck squamous cell carcinoma using the sodium-iodide symporter (NIS) Head Neck 26 2004 265 271 (Pubitemid 38292737)
48. R. Wiggenraad, A. Verbeek-de Kanter, H.B. Kal, M. Taphoorn, T. Vissers, and H. Struikmans Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review Radiother Oncol 98 2011 292 297
49. T. Guerrero Urbano, C.H. Clark, and V.N. Hansen A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer Radiother Oncol 85 2007 36 41 (Pubitemid 47570062)
50. C. Fiorino, R. Valdagni, T. Rancati, and G. Sanguineti Dose-volume effects for normal tissues in external radiotherapy: pelvis Radiother Oncol 93 2009 153 167
51. D.E. Hallahan, H.J. Mauceri, and L.P. Seung Spatial and temporal control of gene therapy using ionizing radiation Nat Med 1 1995 786 791
52. Y. Manome, T. Kunieda, P.Y. Wen, T. Koga, D.W. Kufe, and T. Ohno Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine Hum Gene Ther 9 1998 1409 1417 (Pubitemid 28379080)
53. N. Srivastava, S. Gochhait, P. de Boer, and R.N. Bamezai Role of H2AX in DNA damage response and human cancers Mutat Res 681 2009 180 188
54. K.M. Prise, G. Schettino, M. Folkard, and K.D. Held New insights on cell death from radiation exposure Lancet Oncol 6 2005 520 528 (Pubitemid 40903633)
55. D.T. Goodhead Initial events in the cellular effects of ionizing radiations: clustered damage in DNA Int J Radiat Biol 65 1994 7 17 (Pubitemid 24063524)
56. S.P. Jackson Sensing and repairing DNA double-strand breaks Carcinogenesis 23 2002 687 696 (Pubitemid 34567505)
57. M. de Jager, J. van Noort, D.C. van Gent, C. Dekker, R. Kanaar, and C. Wyman Human Rad50/Mre11 is a flexible complex that can tether DNA ends Mol Cell 8 2001 1129 1135 (Pubitemid 34031814)
58. M. Lisby, J.H. Barlow, R.C. Burgess, and R. Rothstein Choreography of the DNA damage response: spatiotemporal relationships among checkpoint and repair proteins Cell 118 2004 699 713 (Pubitemid 39221730)
59. J.H. Petrini The mammalian Mre11-Rad50-nbs1 protein complex: integration of functions in the cellular DNA-damage response Am J Hum Genet 64 1999 1264 1269 (Pubitemid 30468742)
60. J.H. Lee, and T.T. Paull ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex Science 308 2005 551 554 (Pubitemid 40570585)
61. J.A. Downs, M.C. Nussenzweig, and A. Nussenzweig Chromatin dynamics and the preservation of genetic information Nature 447 2007 951 958 (Pubitemid 46975762)
62. H.D. Halicka, H. Zhao, M. Podhorecka, F. Traganos, and Z. Darzynkiewicz Cytometric detection of chromatin relaxation, an early reporter of DNA damage response Cell Cycle 8 2009 2233 2237
63. Y.C. Kim, G. Gerlitz, and T. Furusawa Activation of ATM depends on chromatin interactions occurring before induction of DNA damage Nat Cell Biol 11 2009 92 96
64. H. van Attikum, and S.M. Gasser Crosstalk between histone modifications during the DNA damage response Trends Cell Biol 19 2009 207 217
65. M.J. Kruhlak, A. Celeste, and G. Dellaire Changes in chromatin structure and mobility in living cells at sites of DNA double-strand breaks J Cell Biol 172 2006 823 834
66. Y. Ziv, D. Bielopolski, and Y. Galanty Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway Nat Cell Biol 8 2006 870 876 (Pubitemid 44151591)
67. Z. Darzynkiewicz, F. Traganos, and D. Wlodkowic Impaired DNA damage response - an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy Eur J Pharmacol 625 2009 143 150
68. M.F. Lavin, D. Delia, and L. Chessa ATM and the DNA damage response. Workshop on ataxia-telangiectasia and related syndromes EMBO Rep 7 2006 154 160
69. J.T. Zilfou, and S.W. Lowe Tumor suppressive functions of p53 Cold Spring Harb Perspect Biol 1 2009 a001883
70. E. Watrin, and J.M. Peters Cohesin and DNA damage repair Exp Cell Res 312 2006 2687 2693 (Pubitemid 44162923)
71. C. Bauerschmidt, C. Arrichiello, and S. Burdak-Rothkamm Cohesin promotes the repair of ionizing radiation-induced DNA double-strand breaks in replicated chromatin Nucleic Acids Res 38 2010 477 487
72. J.T. Powers, S. Hong, C.N. Mayhew, P.M. Rogers, E.S. Knudsen, and D.G. Johnson E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis Mol Cancer Res 2 2004 203 214 (Pubitemid 39031081)
73. X.P. Zhang, F. Liu, and W. Wang Coordination between cell cycle progression and cell fate decision by the p53 and E2F1 pathways in response to DNA damage J Biol Chem 285 2010 31571 31580
74. Z. Xiao, Z. Chen, and A.H. Gunasekera Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents J Biol Chem 278 2003 21767 21773 (Pubitemid 36792580)
75. J. Falck, N. Mailand, R.G. Syljuasen, J. Bartek, and J. Lukas The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis Nature 410 2001 842 847 (Pubitemid 32303786)
76. S. Matsuoka, M. Huang, and S.J. Elledge Linkage of ATM to cell cycle regulation by the Chk2 protein kinase Science 282 1998 1893 1897 (Pubitemid 28555269)
77. J. Zhang, and S.N. Powell The role of the BRCA1 tumor suppressor in DNA double-strand break repair Mol Cancer Res 3 2005 531 539 (Pubitemid 41567272)
78. M.R. Lieber The mechanism of human nonhomologous DNA end joining J Biol Chem 283 2008 1 5
79. M.S. Chaurushiya, and M.D. Weitzman Viral manipulation of DNA repair and cell cycle checkpoints DNA Repair (Amst) 8 2009 1166 1176
80. P.K. Zhou, Y. Sun, and J. An Interaction between viral proteins and hosts and its disturbance in the cellular responses to ionising radiation Int J Radiat Biol 85 2009 587 597
81. H.U. Park, J.H. Jeong, J.H. Chung, and J.N. Brady Human T-cell leukemia virus type 1 Tax interacts with Chk1 and attenuates DNA-damage induced G2 arrest mediated by Chk1 Oncogene 23 2004 4966 4974 (Pubitemid 38938729)
82. H.U. Park, S.J. Jeong, J.H. Jeong, J.H. Chung, and J.N. Brady Human T-cell leukemia virus type 1 Tax attenuates gamma-irradiation-induced apoptosis through physical interaction with Chk2 Oncogene 25 2006 438 447 (Pubitemid 43117629)
83. S.S. Durkin, X. Guo, and K.A. Fryrear HTLV-1 Tax oncoprotein subverts the cellular DNA damage response via binding to DNA-dependent protein kinase J Biol Chem 283 2008 36311 36320
84. Y. Sun, Y.C. Huang, and Q.Z. Xu HIV-1 Tat depresses DNA-PK(CS) expression and DNA repair, and sensitizes cells to ionizing radiation Int J Radiat Oncol Biol Phys 65 2006 842 850 (Pubitemid 43795827)
85. M.T. Liu, Y.T. Chang, and S.C. Chen Epstein-Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity Oncogene 24 2005 2635 2646
86. M.T. Liu, Y.R. Chen, and S.C. Chen Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells Oncogene 23 2004 2531 2539
87. Y.R. Chen, M.T. Liu, Y.T. Chang, C.C. Wu, C.Y. Hu, and J.Y. Chen Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K/Akt/FOXO3a pathway in human epithelial cells J Virol 82 2008 8124 8137
88. C.K. Lai, K.S. Jeng, K. Machida, Y.S. Cheng, and M.M. Lai Hepatitis C virus NS3/4A protein interacts with ATM, impairs DNA repair and enhances sensitivity to ionizing radiation Virology 370 2008 295 309 (Pubitemid 350192554)
89. R.L. DeBiasi, P. Clarke, and S. Meintzer Reovirus-induced alteration in expression of apoptosis and DNA repair genes with potential roles in viral pathogenesis J Virol 77 2003 8934 8947 (Pubitemid 36936103)
90. F.D. Araujo, T.H. Stracker, C.T. Carson, D.V. Lee, and M.D. Weitzman Adenovirus type 5 E4orf3 protein targets the Mre11 complex to cytoplasmic aggresomes J Virol 79 2005 11382 11391 (Pubitemid 41170679)
91. T.H. Stracker, C.T. Carson, and M.D. Weitzman Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex Nature 418 2002 348 352 (Pubitemid 34790688)
92. T.H. Stracker, D.V. Lee, C.T. Carson, F.D. Araujo, D.A. Ornelles, and M.D. Weitzman Serotype-specific reorganization of the Mre11 complex by adenoviral E4orf3 proteins J Virol 79 2005 6664 6673 (Pubitemid 40677297)
93. L.S. Hart, S.M. Yannone, and C. Naczki The adenovirus E4orf6 protein inhibits DNA double strand break repair and radiosensitizes human tumor cells in an E1B-55K-independent manner J Biol Chem 280 2005 1474 1481
94. D. Chowdhury, M.C. Keogh, H. Ishii, C.L. Peterson, S. Buratowski, and J. Lieberman Gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair Mol Cell 20 2005 801 809 (Pubitemid 41740701)
95. L.S. Hart, D. Ornelles, and C. Koumenis The adenoviral E4orf6 protein induces atypical apoptosis in response to DNA damage J Biol Chem 282 2007 6061 6067 (Pubitemid 47100813)
96. S.P. Lees-Miller, M.C. Long, M.A. Kilvert, V. Lam, S.A. Rice, and C.A. Spencer Attenuation of DNA-dependent protein kinase activity and its catalytic subunit by the herpes simplex virus type 1 transactivator ICP0 J Virol 70 1996 7471 7477 (Pubitemid 26339051)
97. J. Parkinson, S.P. Lees-Miller, and R.D. Everett Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase J Virol 73 1999 650 657 (Pubitemid 28565409)
98. C.G. Hadjipanayis, and N.A. DeLuca Inhibition of DNA repair by a herpes simplex virus vector enhances the radiosensitivity of human glioblastoma cells Cancer Res 65 2005 5310 5316 (Pubitemid 40827343)
99. R.T. Abraham Cell cycle checkpoint signaling through the ATM and ATR kinases Genes Dev 15 2001 2177 2196 (Pubitemid 32843830)
100. L. Zou, and S.J. Elledge Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes Science 300 2003 1542 1548 (Pubitemid 36682880)
101. D.E. Wilkinson, and S.K. Weller Herpes simplex virus type I disrupts the ATR-dependent DNA-damage response during lytic infection J Cell Sci 119 2006 2695 2703 (Pubitemid 44184006)
102. C.G. Hadjipanayis, W. Fellows-Mayle, and N.A. Deluca Therapeutic efficacy of a herpes simplex virus with radiation or temozolomide for intracranial glioblastoma after convection-enhanced delivery Mol Ther 16 2008 1783 1788
103. R.E. Meyn, A. Munshi, J.V. Haymach, L. Milas, and K.K. Ang Receptor signaling as a regulatory mechanism of DNA repair Radiother Oncol 92 2009 316 322
104. K. Valerie, A. Yacoub, and M.P. Hagan Radiation-induced cell signaling: inside-out and outside-in Mol Cancer Ther 6 2007 789 801 (Pubitemid 46554549)
105. M. Hingorani, C.L. White, and A. Merron Inhibition of repair of radiation-induced DNA damage enhances gene expression from replication-defective adenoviral vectors Cancer Res 68 2008 9771 9778